Literature DB >> 2175911

Steroidogenic activity of a peptide specified by the reversed sequence of corticotropin mRNA.

B L Clarke1, J E Blalock.   

Abstract

The molecular recognition theory predicts that a reversed (3'----5') reading of an mRNA should yield a peptide that is structurally and functionally similar to that specified in the 5'----3' direction. We tested this idea by synthesizing a corticotropin (ACTH) analogue using a reverse reading of bovine mRNA for ACTH-(1-24). This peptide, designated ACTH-3'----5', had a similar hydropathic profile to native ACTH-5'----3' but had only 30% sequence homology and eight different charge substitutions. ACTH-3'----5' specifically bound to the surface of mouse Y-1 adrenal cells and to polyclonal anti-ACTH antibody. Additionally, ACTH-3'----5' stimulated cAMP synthesis and steroidogenesis in adrenal cells. These findings show that ACTH-3'----5' mimics the corticotropic properties of native ACTH, thereby further validating the molecular recognition theory.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175911      PMCID: PMC55242          DOI: 10.1073/pnas.87.24.9708

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

Review 1.  Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA.

Authors:  J E Blalock
Journal:  Trends Biotechnol       Date:  1990-06       Impact factor: 19.536

2.  Inhibition of adrenocorticotropin effects on adrenal cell membranes by synthetic adrenocorticotropin analogues: correlation of binding and adenylate cyclase activation.

Authors:  D K Ways; C F Zimmerman; D A Ontjes
Journal:  Mol Pharmacol       Date:  1976-09       Impact factor: 4.436

3.  Hydropathic anti-complementarity of amino acids based on the genetic code.

Authors:  J E Blalock; E M Smith
Journal:  Biochem Biophys Res Commun       Date:  1984-05-31       Impact factor: 3.575

Review 4.  Amphiphilic secondary structure: design of peptide hormones.

Authors:  E T Kaiser; F J Kézdy
Journal:  Science       Date:  1984-01-20       Impact factor: 47.728

5.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

6.  Adrenocorticotropin receptors in rat adrenal glomerulosa cells.

Authors:  N Gallo-Payet; E Escher
Journal:  Endocrinology       Date:  1985-07       Impact factor: 4.736

7.  Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA.

Authors:  K L Bost; E M Smith; J E Blalock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

8.  Adrenocorticotropic hormone (ACTH)-lipid interactions. Implications for involvement of amphipathic helix formation.

Authors:  P F Verhallen; R A Demel; H Zwiers; W H Gispen
Journal:  Biochim Biophys Acta       Date:  1984-08-22

9.  Characterization of rat hypothalamic growth hormone-releasing factor.

Authors:  J Spiess; J Rivier; W Vale
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

10.  Suppression of ovulation in the rat by an orally active antagonist of luteinizing hormone-releasing hormone.

Authors:  M B Nekola; A Horvath; L J Ge; D H Coy; A V Schally
Journal:  Science       Date:  1982-10-08       Impact factor: 47.728

View more
  2 in total

1.  Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region.

Authors:  P C Keck; J S Huston
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

2.  Precocious Puberty in a Boy With Bilateral Leydig Cell Tumors due to a Somatic Gain-of-Function LHCGR Variant.

Authors:  Chelsi Flippo; Vipula Kolli; Melissa Andrew; Seth Berger; Tricia Bhatti; Alison M Boyce; Daniel Casella; Michael T Collins; Emmanuèle Délot; Joseph Devaney; Stephen M Hewitt; Thomas Kolon; Ashwini Mallappa; Perrin C White; Deborah P Merke; Andrew Dauber
Journal:  J Endocr Soc       Date:  2022-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.